Atlas Trials

A Study About Fazirsiran in People With and Without Liver Problems

Clinical trial NCT05891158 · COMPLETED

Trial details

NCT number
NCT05891158
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2023-10-05
Primary completion
2025-09-03
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.